Extracellular Vesicles as Biomarkers in Cancer Immunotherapy von Mathew, Matthen, Zade, Mariam, Mezghani, Nadia, Patel, Romil, Wang, Yu, Momen-Heravi, Fatemeh

Volltext

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion von Wu, Xun, Cheng, Yi-Shing Lisa, Matthen, Mathew, Yoon, Angela, Schwartz, Gary K, Bala, Shashi, Taylor, Alison M, Momen-Heravi, Fatemeh

Volltext

760 Interim PK/PD, safety and efficacy data of monotherapy dose escalation of a phase 1/2 study with MDNA11 in patients with advanced solid tumors von To, Minh D, Merchant, Rosemina, Atkinson, Victoria, Bedard, Philippe, Brenner, Warren, Coello, Melissa, Antras, Jesus Fuentes, Galligan, Carole, Lemech, Charlotte, Lloyd, Peter, Karanam, Sudhir Madduri, Margolin, Kim, Mathew, Matthen, Prawira, Amy, Thomas, Sajeve, Twardowski, Przemyslaw, Yavari, Arash, Merchant, Fahar

Volltext

Combining chemotherapy with PD-1 blockade in NSCLC von Mathew, Matthen, Enzler, Thomas, Shu, Catherine A., Rizvi, Naiyer A.

Volltext

AN UNUSUAL CASE OF LUNG ADENOCARCINOMA PRESENTING CONCURRENTLY WITH A RARE INFLAMMATORY PSEUDOTUMOR-LIKE FOLLICULAR DENDRITIC CELL SARCOMA WITH THROMBOCYTOPENIA von SINAWE, HADEER, MATHEW, MATTHEN, SHARMA, RAKSHA, MARTE RESTITUYO, RADENIS, NASSAR, KHALIL

Volltext

Characteristics of patients with EGFR -mutant non-small cell lung cancer (NSCLC) at a diverse metropolitan cancer center von Chen, Lanyi Nora, Schluger, Benjamin, Lagos, Galina, Henick, Brian S., Herzberg, Benjamin, Mathew, Matthen, Shu, Catherine A.

Volltext

ApricityRx companion digital therapeutic for evidence-based mitigation and phenotype-linked molecular characterization of irAEs in patients receiving immune checkpoint therapy (ICT... von Campbell, Matthew T, Zhang, Tian, Chin, Lynda, Warner, Allison Betof, Mathew, Matthen

Volltext

Bone marrow aspirate quality assessment von Safyan, Rachael A., Mathew, Matthen, Marchi, Enrica, Accordino, Melissa Kate

Volltext

Baseline peripheral T-cell composition in relation to radiographic phenotypes of immune-related pneumonitis von Henick, Brian S., Bukhari, Shoiab, Winchester, Robert, Lin, Ziyan, Khodadad-Jamayran, Alireza, Tsirigos, Aristotelis, Lerrer, Shalom S., Adam, Kieran, Salvatore, Mary M., Lagos, Galina, Pabani, Aliyah, Maniar, Rohan, Reiner, Steven L., Dallos, Matthew, Mathew, Matthen, Rizvi, Naiyer A., Mor, Adam

Volltext

INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors von Hilton, John F., Ott, Patrick A., Hansen, Aaron R., Li, Zujun, Mathew, Matthen, Messina, Cristina H., Dave, Vimal, Ji, Xiao, Karpinich, Natalie O., Hirschfeld, Steven, Ballas, Marc, Zandberg, Dan P.

Volltext

Characteristics and outcomes of lung cancer in solid organ transplant recipients von Chen, Lanyi Nora, Spivack, John, Cao, Thu, Saqi, Anjali, Benvenuto, Luke J., Bulman, William A., Mathew, Matthen, Stoopler, Mark B., Arcasoy, Selim M., Stanifer, Bryan P., Rizvi, Naiyer A., Shu, Catherine A.

Volltext

PD-L1 as a biomarker in NSCLC: challenges and future directions von Mathew, Matthen, Safyan, Rachael A, Shu, Catherine A

Volltext

Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors von Bukhari, Shoiab, Henick, Brian S., Winchester, Robert J., Lerrer, Shalom, Adam, Kieran, Gartshteyn, Yevgeniya, Maniar, Rohan, Lin, Ziyan, Khodadadi-Jamayran, Alireza, Tsirigos, Aristotelis, Salvatore, Mary M., Lagos, Galina G., Reiner, Steven L., Dallos, Matthew C., Mathew, Matthen, Rizvi, Naiyer A., Mor, Adam

Volltext

Characteristics and outcomes of Latino patients with EGFR-mutant NSCLC von Mathew, Matthen, Lagos, Galina G., Rao, Nisha, Asmar, Ramsey Nicholas, Liu, Xinhua, Rizvi, Naiyer A., Orjuela, Manuela A., Shu, Catherine A.

Volltext

Updated analysis of the inducible T-cell co-stimulatory receptor (ICOS) agonist, GSK3359609 (GSK609), combination with pembrolizumab (PE) in patients (pts) with anti-PD-1/L1 treatm... von Angevin, Eric, Groenland, Stefanie L., Lim, Annette May Ling, Martin-Liberal, Juan, Moreno, Victor, Trigo, Jose Manuel, Le Tourneau, Christophe, Mathew, Matthen, Cho, Daniel C., Hansen, Aaron Richard, Vicente, David, Maio, Michele, Italiano, Antoine, Bauman, Jessica Ruth, Chisamore, Michael Jon, Zhou, Helen, Ellis, Catherine Elizabeth, Ballas, Marc S., Hoos, Axel, Rischin, Danny

Volltext

Modulation of Angiotensin II–Mediated Cardiac Remodeling by the MEF2A Target Gene Xirp2 von McCalmon, Sarah A, Desjardins, Danielle M, Ahmad, Saad, Davidoff, Katharine S, Snyder, Christine M, Sato, Kaori, Ohashi, Koji, Kielbasa, Ondra M, Mathew, Matthen, Ewen, Elizabeth P, Walsh, Kenneth, Gavras, Haralambos, Naya, Francisco J

Volltext

Myomaxin Is a Novel Transcriptional Target of MEF2A That Encodes a Xin-related α-Actinin-interacting Protein von Huang, Hsuan-Ting, Brand, Ondra M., Mathew, Matthen, Ignatiou, Christos, Ewen, Elizabeth P., Mccalmon, Sarah A., Naya, Francisco J.

Volltext

Myomaxin Is a Novel Transcriptional Target of MEF2A That Encodes a Xin-related α-Actinin-interacting Protein von Hsuan-Ting Huang, Ondra M. Brand, Matthen Mathew, Christos Ignatiou, Elizabeth P. Ewen, Sarah A. Mccalmon, Francisco J. Naya

Volltext

Additional file 2 of Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion von Wu, Xun, Yi-Shing Lisa Cheng, Matthen, Mathew, Yoon, Angela, Schwartz, Gary K., Bala, Shashi, Taylor, Alison M., Momen-Heravi, Fatemeh

Volltext bestellen

Additional file 4 of Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion von Wu, Xun, Yi-Shing Lisa Cheng, Matthen, Mathew, Yoon, Angela, Schwartz, Gary K., Bala, Shashi, Taylor, Alison M., Momen-Heravi, Fatemeh

Volltext bestellen